5 David Einhorn NeuBase Therapeutics Trades
David Einhorn's position in NeuBase Therapeutics is currently worth $51.5k. That's 0.00% of their equity portfolio (37th largest holding). The investor owns 3.63% of the outstanding NeuBase Therapeutics stock. David Einhorn started to build up the position in NeuBase Therapeutics in Q3 2019 and continued to invest until Q2 2021. Since then they sold 1 shares. The investor's estimated purchase price is $294M, resulting in a loss of 100%.
Avg closing price
Price range
Sold 0.0% shares (-1 shares)
Q2 2023
Avg closing price
$57.69
Price range
$1.87
-
$82.40
Increased shares by 34.5% (+35k shares)
Q2 2021
Avg closing price
$2,209.21
Price range
$1,852.00
-
$2,936.00
Increased shares by 6.5% (+6.19k shares)
Q3 2020
Avg closing price
$3,262.72
Price range
$2,900.00
-
$3,884.00
Increased shares by 23.7% (+18.2k shares)
Q2 2020
Avg closing price
$3,347.37
Price range
$2,676.00
-
$4,604.00
New holding (+76.9k shares)
Q3 2019
Avg closing price
$1,757.18
Price range
$3.15
-
$2,636.00
News about NeuBase Therapeutics Inc and David Einhorn
David Einhorn ¡ª Notorious Tesla Short Seller ¡ª Just Had His Best Quarter Ever
Greenlight Capital hedge fund manager and notorious value investor David Einhorn just released his annual letter to investors, which revealed a record quarte...